Skip to content

Study · Systematic review · 2016

1 result

Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments.

Harrison F, Aerts L, Brodaty H

Current psychiatry reports1 Nov 2016Cited by 46 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanSystematic reviewEfficacy outcome

    In people with dementia, a systematic review found that oxytocin study results for apathy were inconclusive.

    In plain wordsIn people with dementia, a review found that studies of oxytocin for apathy gave inconclusive results.

    Peptide
    Oxytocin
    Outcome
    Direction not reportedApathy in dementia
    Study

    n: not reported in source

    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    Dose not stated

    Source sentences

    Summary
    while stimulants, analgesics, and oxytocin study results were inconclusive.
    1 context sentence
    Summary · context
    We evaluated evidence of the efficacy of pharmacotherapies for apathy in dementia from studies since 2013.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 01:30 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.